Asthma Study Dunedin FpA
Asthma Study
Dunedin
Clinical Trial exploring the effectiveness of a new combination inhaler to prevent asthma attacks.
Description
What to expect
Ages
12 years +
Duration
Variable
Compensation
Participants will be reimbursed for reasonable study-related travel expenses.
Eligibility Criteria
You may be eligible to take part if you:
Locations
Asthma is a common and diverse lung condition that can make it hard to breathe. It causes the airways in the lungs to become inflamed and narrow, leading to symptoms like coughing, wheezing, chest tightness, shortness of breath, and mucus production. Some people with asthma may experience long-term damage to their airways, which can be serious.
Momentum Clinical Research is now enrolling people over 16 years old with asthma for a research study of an investigational medication which is a new inhaler that combines two medicines.
The goal of the study is to assess the efficiency of the combination of the 2 medicines in preventing asthma attacks.
The investigational treatment is an inhaler designed to be used as a rescue treatment when asthma symptoms get worse.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.